Stauffer JL - Search Results

1

Physician characteristics associated with treatment initiation patterns in idiopathic pulmonary fibrosis.

LaCamera PP, Limb SL, Haselkorn T, Morgenthien EA, Stauffer JL, Wencel ML. LaCamera PP, et al. Among authors: stauffer jl. Chron Respir Dis. 2019 Jan-Dec;16:1479973119879678. doi: 10.1177/1479973119879678. Chron Respir Dis. 2019. PMID: 31558049 Free PMC article.

2

Pirfenidone in patients with idiopathic pulmonary fibrosis and more advanced lung function impairment.

Nathan SD, Costabel U, Albera C, Behr J, Wuyts WA, Kirchgaessler KU, Stauffer JL, Morgenthien E, Chou W, Limb SL, Noble PW. Nathan SD, et al. Among authors: stauffer jl. Respir Med. 2019 Jul;153:44-51. doi: 10.1016/j.rmed.2019.04.016. Epub 2019 Apr 24. Respir Med. 2019. PMID: 31153107 Free article. Clinical Trial.

3

Real-World Practice Patterns for Prevention and Management of Potential Adverse Events with Pirfenidone in Patients with Idiopathic Pulmonary Fibrosis.

Wencel ML, Haselkorn T, Limb SL, Stauffer JL, Morgenthien E, Raimundo K, LaCamera PP. Wencel ML, et al. Among authors: stauffer jl. Pulm Ther. 2018 Jun;4(1):103-114. doi: 10.1007/s41030-018-0056-8. Epub 2018 May 29. Pulm Ther. 2018. PMID: 32026247 Free PMC article.

4

FVC variability in patients with idiopathic pulmonary fibrosis and role of 6-min walk test to predict further change.

Nathan SD, Yang M, Morgenthien EA, Stauffer JL. Nathan SD, et al. Among authors: stauffer jl. Eur Respir J. 2020 May 14;55(5):1902151. doi: 10.1183/13993003.02151-2019. Print 2020 May. Eur Respir J. 2020. PMID: 32029447 Free PMC article.

5

Patient and site characteristics associated with pirfenidone and nintedanib use in the United States; an analysis of idiopathic pulmonary fibrosis patients enrolled in the Pulmonary Fibrosis Foundation Patient Registry.

Holtze CH, Freiheit EA, Limb SL, Stauffer JL, Raimundo K, Pan WT, Flaherty KR, Kim HJ. Holtze CH, et al. Among authors: stauffer jl. Respir Res. 2020 Feb 10;21(1):48. doi: 10.1186/s12931-020-1315-4. Respir Res. 2020. PMID: 32041621 Free PMC article.

6

Using forced vital capacity (FVC) in the clinic to monitor patients with idiopathic pulmonary fibrosis (IPF): pros and cons.

Nathan SD, Wanger J, Zibrak JD, Wencel ML, Burg C, Stauffer JL. Nathan SD, et al. Among authors: stauffer jl. Expert Rev Respir Med. 2021 Feb;15(2):175-181. doi: 10.1080/17476348.2020.1816831. Epub 2020 Sep 28. Expert Rev Respir Med. 2021. PMID: 32985286 Free article. Review.

7

Changes in Neutrophil-Lymphocyte or Platelet-Lymphocyte Ratios and Their Associations with Clinical Outcomes in Idiopathic Pulmonary Fibrosis.

Nathan SD, Mehta J, Stauffer J, Morgenthien E, Yang M, Limb SL, Bhorade S. Nathan SD, et al. J Clin Med. 2021 Apr 1;10(7):1427. doi: 10.3390/jcm10071427. J Clin Med. 2021. PMID: 33916077 Free PMC article.

8

Cardiovascular Risks, Bleeding Risks, and Clinical Events from 3 Phase III Trials of Pirfenidone in Patients with Idiopathic Pulmonary Fibrosis.

Glassberg MK, Nathan SD, Lin CY, Morgenthien EA, Stauffer JL, Chou W, Noble PW. Glassberg MK, et al. Among authors: stauffer jl. Adv Ther. 2019 Oct;36(10):2910-2926. doi: 10.1007/s12325-019-01052-y. Epub 2019 Aug 10. Adv Ther. 2019. PMID: 31401786 Free PMC article. Clinical Trial.

9

FG-3019 anti-connective tissue growth factor monoclonal antibody: results of an open-label clinical trial in idiopathic pulmonary fibrosis.

Raghu G, Scholand MB, de Andrade J, Lancaster L, Mageto Y, Goldin J, Brown KK, Flaherty KR, Wencel M, Wanger J, Neff T, Valone F, Stauffer J, Porter S. Raghu G, et al. Eur Respir J. 2016 May;47(5):1481-91. doi: 10.1183/13993003.01030-2015. Epub 2016 Mar 10. Eur Respir J. 2016. PMID: 26965296 Free article. Clinical Trial.

10

Correction to: Cardiovascular Risks, Bleeding Risks, and Clinical Events from 3 Phase III Trials of Pirfenidone in Patients with Idiopathic Pulmonary Fibrosis.

Glassberg MK, Nathan SD, Lin CY, Morgenthien EA, Stauffer JL, Chou W, Noble PW. Glassberg MK, et al. Among authors: stauffer jl. Adv Ther. 2019 Oct;36(10):2927-2929. doi: 10.1007/s12325-019-01082-6. Adv Ther. 2019. PMID: 31502216 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

51 results

Search Page

Filters